Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc.,...

MENLO PARK, Calif. & ALAMEDA, Calif.-- --Asterias Biotherapeutics, Inc. and BioTime, Inc. jointly announced today the closing of the transactions under the Asset Contribution Agreement with Geron Corporation, previously announced on January 7, 2013, pursuant to which Asterias Biotherapeutics acquired Geron's human embryonic stem cell assets, as ... (more)

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131001006076&newsLang=en&ndmConfigId=1000639&vnsId=41